Copyright Notice
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Bookshelf ID: NBK621071PMID: 41730074
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 2172870-89-0
Drug Levels and Effects
Summary of Use during Lactation
No information is available on the use of paltusotine during breastfeeding. Because paltusotine is 99% bound to plasma proteins, the amount in milk is likely to be low. If a mother requires paltusotine, it is not a reason to discontinue breastfeeding.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Paltusotine
CAS Registry Number
2172870-89-0
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Review Remibrutinib.[Drugs and Lactation Database (...]Review Remibrutinib.. Drugs and Lactation Database (LactMed®). 2006
- Review Resmetirom.[Drugs and Lactation Database (...]Review Resmetirom.. Drugs and Lactation Database (LactMed®). 2006
- Review Mavacamten.[Drugs and Lactation Database (...]Review Mavacamten.. Drugs and Lactation Database (LactMed®). 2006
- Review Paltusotine: First Approval.[Drugs. 2026]Review Paltusotine: First Approval.Lee A. Drugs. 2026 Feb; 86(2):259-263. Epub 2025 Nov 26.
- Review Oral Octreotide Capsules and Paltusotine in Management of Acromegaly.[touchREV Endocrinol. 2024]Review Oral Octreotide Capsules and Paltusotine in Management of Acromegaly.McLaren DS, Seejore K, Lynch J, Murray RD. touchREV Endocrinol. 2024 Apr; 20(1):32-36. Epub 2023 Nov 8.
- Paltusotine - Drugs and Lactation Database (LactMed®)Paltusotine - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...